Study group and control group description.

*: at time of DEHP measurement (ECMO = extracorporeal membrane oxygenation, SAPS = simplified acute physiology score, DEHP = di(2-ethylhexyl)phthalate, MEHP = mono(2-ethylhexyl)phthalate, PC = packed cells, CF = cystic fibrosis, ILD = interstitial lung disease, PH = pulmonary hypertension, PE = pulmonary embolism, ARDS = acute respiratory distress syndrome, CLAD = chronic lung allograft dysfunction, AECOPD = acute exacerbation of chronic obstructive pulmonary disease).*：在邻苯二甲酸二(2-乙基己基)酯（DEHP）检测时，各缩写含义如下：体外膜肺氧合（ECMO，extracorporeal membrane oxygenation）、简化急性生理学评分（SAPS，simplified acute physiology score）、邻苯二甲酸二(2-乙基己基)酯（DEHP，di(2-ethylhexyl)phthalate）、单(2-乙基己基)邻苯二甲酸酯（MEHP，mono(2-ethylhexyl)phthalate）、浓缩红细胞（PC，packed cells）、囊性纤维化（CF，cystic fibrosis）、间质性肺疾病（ILD，interstitial lung disease）、肺动脉高压（PH，pulmonary hypertension）、肺栓塞（PE，pulmonary embolism）、急性呼吸窘迫综合征（ARDS，acute respiratory distress syndrome）、慢性肺同种异体移植功能障碍（CLAD，chronic lung allograft dysfunction）、慢性阻塞性肺疾病急性加重（AECOPD，acute exacerbation of chronic obstructive pulmonary disease）